FDA Inspection 1004242 — Department of Defense - Army

Department of Defense - Army — FEI 1677437

The FDA completed an inspection of Department of Defense - Army on February 1, 2017 in San Antonio, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 1, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
San Antonio, TX (United States)

Citations

IDCFRDescription
7621 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs